Ryvu Therapeutics
Develop therapeutics that address clinical limitations of current treatments in oncology. Learn more
Launch date
Employees
Market cap
CAD430m
Enterprise valuation
CAD361m (Public information from Sep 2024)
Share price
PLN54.2 RVU.WA
Kraków Lesser Poland Voivodeship (HQ)
Authorizing premium user...